癌性心脏病 癌性心脏病
1From Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Journal of the advanced practitioner in oncology
|September 27, 2024
概括
癌性心脏病 (CHD) 是神经内分泌瘤的严重并发症. 使用生物标志物和心声回声图的早期查对于及时诊断和管理这种疾病至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 癌症性心脏病 (CHD) 是一种罕见的,与癌症综合征相关的高级神经内分泌瘤的严重并发症.
- 瘤分泌的血管活性物质,主要是血清素,导致特征性的右侧心脏膜疾病和随后的右心力衰竭.
研究的目的:
- 强调在患有神经内分泌瘤和癌症综合征的患者中查癌状心脏病 (CHD) 的重要性.
- 强调需要对心脏病采取适当及时的诊断措施.
- 倡导在治疗心脏病患者时提供多学科护理.
主要方法:
- 监测N-终端亲B型尿素 (NT-proBNP) 的水平.
- 在尿液中评估5-氨酸 (5-HIAA).
- 使用心脏回声心脏成像进行心脏评估.
主要成果:
- 目前对心血管疾病的查实践往往不充分,导致诊断延迟.
- 生物标志物 (NT-proBNP,5-HIAA) 和心声扫描是心脏病查的关键工具.
- 心血管疾病的诊断和管理需要一个协调的方法.
结论:
- 对患有神经内分泌瘤和癌症综合征的患者来说,适当和及时的癌症性心脏病查是必不可少的.
- 涉及医疗瘤学,心脏病学和心胸外科手术的多学科护理是管理心脏病的最佳方式.
- 早期检测和干预可以改善这种罕见但严重的疾病患者的治疗结果.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Cardiomyopathy I: Introduction and Classification
2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


